These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10758697)

  • 1. [Prevalence of the activated protein C resistance in indigenous and Black populations of the western Venezuela].
    Vizcaíno G; Torres E; Quintero J; Herrmann F; Grimm R; Diez-Ewald M; Arteaga-Vizcaíno M; Pérez-Requejo JL; Colina-Araujo J
    Invest Clin; 2000 Mar; 41(1):29-36. PubMed ID: 10758697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk.
    Sharma A; Bhakuni T; Biswas A; Ranjan R; Kumar R; Kishore K; Mahapatra M; Jairajpuri MA; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):596-600. PubMed ID: 26699866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
    Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
    Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden mutation in one family of Chinese origin.
    Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
    Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
    Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
    Baig MA
    Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [One Chinese case of F V Leiden mutation associated with APC resistance].
    Wu J; Gu JM; Morrisey JH; Esmon N
    Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):453-6. PubMed ID: 15625834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
    Yanqing H; Fangping C; Qinzhi X; Zaifu J; Guangping W; Xiaoxia Z; Xiaoqun P; Xiaobo
    Thromb Haemost; 2003 Mar; 89(3):446-51. PubMed ID: 12624626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance.
    Sayinalp N; Haznedaroğlu IC; Aksu S; Büyükaşik Y; Göker H; Parlak H; Ozcebe OI; Kirazli S; Dündar SV; Gürgey A
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):265-70. PubMed ID: 15247984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
    Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
    Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the Factor V E666D Mutation and Its Correlation With Activated Protein C Resistance in the Chinese Population.
    Xin-Guang C; Yong-Qiang Z; Shu-Jie W; Lian-Kai F; Hua-Cong C
    Clin Appl Thromb Hemost; 2015 Jul; 21(5):480-3. PubMed ID: 24335247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
    Loew A; Jacob D; Neuhaus P; Riess H
    Transplantation; 2005 May; 79(10):1422-7. PubMed ID: 15912114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.
    Sedano-Balbás S; Lyons M; Cleary B; Murray M; Gaffney G; Maher M
    BMC Pregnancy Childbirth; 2010 Mar; 10():11. PubMed ID: 20214832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.
    Sharma A; Singh K; Biswas A; Ranjan R; Kishor K; Kumar R; Pandey H; Kamal VK; Saxena R
    J Thromb Thrombolysis; 2017 Feb; 43(2):217-223. PubMed ID: 28063132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activated protein C resistance and factor V Leiden: clinical interest].
    Guermazi S; Znazen R
    Pathol Biol (Paris); 2011 Oct; 59(5):281-5. PubMed ID: 19896782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.